In Response to COVID-19 Pandemic, Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine
Share this article Share this article ATMA Journey Centers and SYNTAC Institute collaborate to submit a Group Application for Section 56 Exemption from Health Canada to access psychedelic-assisted therapy CALGARY, AB, Feb. 2, 2021 /CNW/ - ATMA Journey Centers Inc. (" ATMA"), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians struggling with adverse mental and emotional health conditions. David Harder, Co-CEO of ATM...
Source: newswire.ca